News Releases News Releases HOME HOME

February 7, 2003

- 50th Anniversary of "Semper" Brand -
Taisho to Launch "Semper QT <Junior>"
Motion Sickness Remedy for Children that Dissolves Fast Without Water

Taisho Pharmaceutical Co., Ltd. (President: Akira Uehara) is to launch "Semper QT <Junior>", a motion sickness remedy for children, on February 17.

"Semper QT <Junior>", which uses "Zydis" technology, dissolves almost instantly on contact with water. Thanks to this technology, it is effective even when motion sickness has already begun and is easy to take, even for children, as it dissolves instantly on contact with saliva in the mouth and need not be taken with water. In a survey conducted by Taisho Pharmaceutical, the most common requirements of motion sickness remedies cited by users were "can be taken immediately, without water, and convenient for use when on the move", "effective action" and "effective even when motion sickness has already begun". The new motion sickness remedy "Semper QT <Junior>" meets exactly these needs.

This year marks the 50th anniversary of the launch of the "Semper" brand in 1953. Over the years, Taisho Pharmaceutical has expanded the series in response to user needs, developing new product formats and modifying initial prescriptions and "Semper" has become Japan's leading brand of motion sickness remedies. The addition of "Semper QT <Junior>" further strengthens the Semper series.

About "Zydis" technology
A technology for the manufacture of pharmaceutical products patented worldwide by the British company R. P. Scherer Corp. The technology is an adaptation of freeze-drying techniques used in the manufacture of food products such as instant coffee, and involves freezing then drying a liquid to form a highly porous sponge-like solid that dissolves quickly on contact with water.

Product features
- A tablet-form remedy using Zydis technology that dissolves almost instantly and can be taken without water
- Effective even when motion sickness has already begun
- Pleasant strawberry flavor

Product specification
Product name Semper QT <Junior>
Suggested retail price 6 tablet pack ¥650
Ingredients (in every 2 tablets)
d-chlorpheniramine maleate 1.32 mg
Scopolamine hydrobromide 0.16 mg
Indications Relief and prevention of dizziness, nausea and headaches resulting from motion
Dosage Place the appropriate number of tablets in the mouth and allow to dissolve.
To prevent motion sickness, take a single dosage 30 minutes prior to boarding.
Repeat the dosage as required, at intervals of no less than 4 hours.
Age Dosage Frequency
11-14 years 2 tablets Up to 2 doses a day
5-10 years 1 tablet
under 5 years Do not administer to children under age 5.
Date of sale February 17, 2003
Expected sales ¥100 million (in 12 months from launch)